Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Boehringer Ingelheim
Dow
Johnson and Johnson
Medtronic

Last Updated: January 27, 2023

Droxidopa - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for droxidopa and what is the scope of patent protection?

Droxidopa is the generic ingredient in two branded drugs marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Annora, Aurobindo Pharma Ltd, Bionpharma Inc, Celltrion, Hikma, Lupin Pharms, Msn Pharms Inc, Sciegen Pharms Inc, Slate Run Pharma, Sun Pharm, Teva Pharms Usa Inc, Tris Pharma Inc, Upsher Smith Labs, Zydus Pharms, and Lundbeck Na Ltd, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for droxidopa. Seventeen suppliers are listed for this compound.

Summary for droxidopa
Drug Prices for droxidopa

See drug prices for droxidopa

Recent Clinical Trials for droxidopa

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
H. Lundbeck A/SPhase 2
Loma Linda UniversityPhase 2
Stephen G. Kaler, MDPhase 1/Phase 2

See all droxidopa clinical trials

Pharmacology for droxidopa
Physiological Effect Increased Blood Pressure
Medical Subject Heading (MeSH) Categories for droxidopa

US Patents and Regulatory Information for droxidopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msn Pharms Inc DROXIDOPA droxidopa CAPSULE;ORAL 211741-003 Feb 18, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 AB RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Slate Run Pharma DROXIDOPA droxidopa CAPSULE;ORAL 215265-003 Nov 1, 2021 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma Ltd DROXIDOPA droxidopa CAPSULE;ORAL 214387-003 Feb 18, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Tris Pharma Inc DROXIDOPA droxidopa CAPSULE;ORAL 214543-003 May 5, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lupin Pharms DROXIDOPA droxidopa CAPSULE;ORAL 211652-003 Feb 18, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Zydus Pharms DROXIDOPA droxidopa CAPSULE;ORAL 211818-002 Feb 18, 2021 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.